CPCI (Cairo Pharma): The Profitability Powerhouse
CPCI (Cairo Pharma): The Profitability Powerhouse 💊🚀
The Driver: A true "earner" with a massive 50% ROE.
Net profits continue to climb, supported by a 9.4% growth in H1 FY2025/26. 📈💰
Sharia Status: ❌ Non-Compliant.
Not a member of the EGX33 Shariah Index due to financial ratio filters (interest income). 🚫📜
The Technicals: High-volume Triangle Breakout today confirms bullish intent.
However, the Bearish Divergence from October remains a warning
the 272.40 EGP level a successful retest. 📐🧪
The Targets: 🎯 ATH: 296.30 EGP | 🎯 Fair Value: 320.00 EGP.
The Safety Net: Keep a strict Stop Loss at the 265.00 EGP main support level. 🛡️🛑
Verdict: Superior fundamentals but needs technical confirmation.
If 272.40 holds, the path to 320.00 is wide open! 🌟🔥
If you like my posts, please follow and boost 🙌
The Driver: A true "earner" with a massive 50% ROE.
Net profits continue to climb, supported by a 9.4% growth in H1 FY2025/26. 📈💰
Sharia Status: ❌ Non-Compliant.
Not a member of the EGX33 Shariah Index due to financial ratio filters (interest income). 🚫📜
The Technicals: High-volume Triangle Breakout today confirms bullish intent.
However, the Bearish Divergence from October remains a warning
the 272.40 EGP level a successful retest. 📐🧪
The Targets: 🎯 ATH: 296.30 EGP | 🎯 Fair Value: 320.00 EGP.
The Safety Net: Keep a strict Stop Loss at the 265.00 EGP main support level. 🛡️🛑
Verdict: Superior fundamentals but needs technical confirmation.
If 272.40 holds, the path to 320.00 is wide open! 🌟🔥
If you like my posts, please follow and boost 🙌
Publicações relacionadas
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.
Publicações relacionadas
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.